Individual and Diurnal Variations in Rectal Temperature,Respiration, and Heart Rate of Pack Donkeys during the Early Rainy Season

Six Nubian pack donkeys were used to determine variations in rectal temperature (RT), respiratory rate (RR), and heart rate (HR) during the early rainy season. The donkeys exhibited a diurnal range of RT, RR, and HR of 34.7 to 38.7°C, 15 to 75 breaths/minute, and 36 to 72 beats/minute, respectively, with peak mean values at 2:00 pm and a trough shortly after sunrise (7:00 am). The amplitude of the diurnal rhythm of RT and RR was not correlated with the diurnal range of ambient temperature (AT) and relative humidity (RH). Although mean diurnal RTs were positively correlated with corresponding ATs, mean daily RTs were not significantly correlated with corresponding ATs. Diurnal and daily variations in RT of donkeys, like those of other ungulates, therefore, appear to reflect an endogenous rhythm, which may be largely independent of fluctuations in environmental thermal load. The mean maximum AT and RH, and the corresponding RR and HR values, fell above the normal range for donkeys in the tropics. The season was meteorologically stressful to the donkeys, imposing significant changes in the RT, RR, and HR parameters requiring responses to maintain homeostasis. The values of the amplitude in RT, RR, and HR obtained in individual donkeys were higher than the corresponding values obtained during the hourly recordings, indicating that it is more important to evaluate the individual's vital parameters in reaching conclusion of fitness for work in donkeys. The hourly recordings have shown the hours of the day (11:00 am to 4:00 pm) that are potentially meteorologically stressful for donkeys to be used for packing during the season.     

Effect of Lavender Aromatherapy on Acute-Stressed Horses

Methods to reduce the effects of acute stress could benefit the equine industry; therefore, the objective of this experiment was to determine whether aromatherapy would hasten the recovery time in acute-stressed horses. A total of seven horses were used in this experiment, using a crossover design where each horse received each treatment 7 days apart. The heart rates (HRs) and respiratory rates (RRs) were recorded for each horse at rest in stalls; then an air horn was blown twice for 15 seconds. The horses were allowed 60 seconds to calm, and then the stressed HRs and RRs were recorded. Control-treated horses were then exposed to humidified air, whereas aromatherapy-treated horses were exposed to humidified air with a 20% mixture of 100% pure lavender essential oil for 15 minutes. Following the 15-minute control or aromatherapy treatment, the recovery HRs and RRs were recorded (15 minutes). There were no statistical differences (P > .05) between the control and aromatherapy treatment for resting HR 33.7 ± 3.6 versus 34.0 ± 3.1 beats per minute (bpm), or change to increased HR in response to the air horn. However, the change in HR, after treatment, was significantly greater (P < .02) after aromatherapy (−9.25 ± 3.4 bpm) compared with the control treatment (0.29 ± 1.5 bpm). The RR did not differ (P > .05) between the control or aromatherapy treatment groups for the resting RR or change in RR. These results demonstrate that lavender aromatherapy can significantly decrease HR after an acute stress response and signal a shift from the sympathetic nervous control from the parasympathetic system.     

Effects of intravenously administered glycopyrrolate in anesthetized horses.

The purpose of this study was to determine the heart rate (HR) and blood pressure (BP) effect of glycopyrrolate in anesthetized horses with low HR (< or = 30 beats/min). The horses were randomly treated with glycopyrrolate (2.5 micrograms/kg body weight (BW)) or saline, intravenously (i.v.) (n = 17). If HR failed to increase (by > 5 beats/min within 10 min), glycopyrrolate (same dose) was administered. Heart rate increased by > 5 beats/min in 3 out of 9 horses following the initial glycopyrrolate treatment. Overall changes in HR and mean BP were not significantly different, while systolic and diastolic BP increased significantly (P < 0.025 using a Bonferroni corrected paired t-test). On the 2nd treatment, 3 out of 7 horses given 2.5 micrograms/kg BW glycopyrrolate, and 4 out of 5 horses given 5.0 micrograms/kg BW (total dose) showed an increase in heart rate of > 5 beats/min, which was significant. A significant increase in BP was produced following treatment with 2.5 micrograms/kg BW, but not following 5.0 micrograms/kg BW. A final increase in HR, of > 5 beats/min, was associated with a significant rise in BP (P < 0.05 using an unpaired t-test). In conclusion, an increase in HR can occur with 2.5 to 5.0 micrograms of glycopyrrolate/kg BW, i.v., and results in improvement in BP in anesthetized horses.     

Inhibition of Nitric Oxide Synthase with L-NAME Does Not Increase Lactate Production at Rest or During Short-term High-intensity Exercise in Thoroughbred Horses

The present study was carried out to determine whether inhibition of nitric oxide (NO) synthase promotes anaerobic metabolism in exercising horses, resulting in a significantly increased blood lactate concentration. N -nitro-L-arginine methyl ester (L-NAME) is a potent inhibitor of NO synthase that has been tested in horses and other species. Two sets of experiments, namely placebo (saline control) and L-NAME (20 mg/kg, IV) studies, were carried out on seven healthy, sound, exercise-trained, Thoroughbred horses in random order, 6 to 7 days apart. In both experiments, an incremental exercise protocol was used and data were obtained at rest, during submaximal exercise performed at 8 m/s on a 4.5% uphill grade, and during galloping at 14 m/s on a 4.5% uphill grade – a workload that not only elicited maximal heart rate and induced exercise-induced pulmonary haemorrhage, but also could not be sustained for more than 90 s. Measurements were also made in the recovery period. Mixed-venous blood samples, obtained at matched intervals in the two sets of experiments, were analysed in triplicate for determining the lactate concentration. Following administration of L-NAME, significant bradycardia occurred at rest (27±1 vs 37±2 beats/min in the placebo trials; p<0.0001) as well as during submaximal exercise (183±4 vs 200±4 beats/min in the placebo trials; p<0.001), but the heart rate increased during galloping at 14 m/s on a 4.5% uphill grade to reach values observed in the placebo trials (215±2 beats/min) and significant differences were not found. At rest, the mixed-venous blood lactate concentration was similar in the two experiments. With exercise, the mixed-venous blood lactate concentration increased progressively as work intensity increased in both trials, but significant differences were not found between the placebo and the L-NAME experiments during submaximal exercise, near-maximal exercise or recovery. These experiments demonstrated that inhibition of NO synthase in Thoroughbred horses does not promote enhanced anaerobic metabolism at rest or during short-term incremental exercise leading to galloping at maximal heart rate.     

Xylazine-induced sedation in axis deer (Axis axis) and its reversal by atipamezole

Eight free-ranging axis deer (Axis axis) were captured in drive nets and injected with xylazine (3.4±0.1 mg/kg; mean ±SEM) intramuscularly using a hand-held syringe. Xylazine induced complete immobilization and sedation in three animals, heavy sedation in three, and moderate sedation in two. The mean induction time was 10.4±1.0 min. The mean rectal temperature, heart and respiratory rates of immobilized animals were 39.2±0.4°C, 75.5±6.5 beats/min and 62.1±4.2 breaths/min, respectively.All the animals were given atipamezole intravenously for reversal. The mean time from injection of xylazine to administration of atipamezole was 37.8±4.6 min. A dose ratio (w/w) for xylazine:atipamezole-HCl of 10:1 was used. The mean time from injection of atipamezole to mobility was 2.41±0.58 min.Atipamezole given intravenously effectively antagonized xylazine-induced sedation in axis deer. Only one animal showed signs of overalertness after reversal and no cases of resedation were observed.Abbreviations i.m. intramuscular(ly) - i.v. intravenous(ly) - SEM standard error of the mean     

Evaluation of the sedative and clinical effects of xylazine,detomidine, medetomidine and dexmedetomidine in miniature donkeys

ABSTRACT

Aim: To evaluate the sedative and clinical effects of I/V xylazine, detomidine, medetomidine and dexmedetomidine in miniature donkeys.

Methods: Seven clinically healthy, male adult miniature donkeys with a mean age of 6 years and weight of 105?kg, were assigned to five I/V treatments in a randomised, cross-over design. They received either 1.1?mg/kg xylazine, 20?μg/kg detomidine, 10?μg/kg medetomidine, 5?μg/kg dexmedetomidine or saline, with a washout period of ≥7 days. The degree of sedation was scored using a 4-point scale by three observers, and heart rate (HR), respiration rate (RR), rectal temperature and capillary refill time (CRT) were recorded immediately before and 5, 10, 15, 30, 60, 90 and 120 minutes after drug administration.

Results: All saline-treated donkeys showed no sedation at any time, whereas the donkeys treated with xylazine, detomidine, medetomidine and dexmedetomidine had mild or moderate sedation between 5 and 60 minutes after treatment, and no sedation after 90 minutes. All animals recovered from sedation without complication within 2 hours. The mean HR and RR of saline-treated donkeys did not change between 0 and 120 minutes after administration, but the mean HR and RR of donkeys treated with xylazine, detomidine, medetomidine and dexmedetomidine declined between 5 and 60 minutes after drug administration. The mean rectal temperature of all treated donkeys did not change between 0 and 120 minutes after administration. The CRT for all donkeys was ≤2 seconds at all times following each treatment.

Conclusions and clinical relevance: Administration of xylazine at 1.1?mg/kg, detomidine at 20?μg/kg, medetomidine at 10?μg/kg and dexmedetomidine at 5?μg/kg resulted in similar sedation in miniature donkeys. Therefore any of the studied drugs could be used for sedation in healthy miniature donkeys.     

Effect of exercise on serum concentration of cartilage oligomeric matrix protein in Thoroughbreds

OBJECTIVE: To evaluate changes in serum cartilage oligomeric matrix protein (COMP) concentrations in response to exercise in horses. ANIMALS: 15 horses in experiment 1 and 27 horses in experiment 2. PROCEDURES: In experiment 1, 15 Thoroughbreds free of orthopedic disease underwent a standardized exercise protocol. Running velocity and heart rate (HR) were recorded, and blood samples were collected immediately before (baseline) and 1, 5, and 24 hours after a single episode of exercise. In experiment 2, 27 horses underwent 9 stages of a training program in which each stage consisted of 4 to 8 consecutive daily workouts followed by a rest day. Blood samples were collected immediately before the first and final daily workouts in each stage. Serum COMP concentrations were measured via inhibition ELISA with a monoclonal antibody (14G4) against equine COMP. RESULTS: In experiment 1, mean serum COMP concentration was significantly higher than baseline 1 and 5 hours after exercise and returned to baseline concentrations 24 hours after exercise. Mean serum baseline COMP concentration increased as the velocity of running at maximum HR and at an HR of 200 beats/min increased, being significantly higher during the third and fourth exercise tests than during the first. In experiment 2, mean baseline COMP concentration at the final workout of each stage was significantly higher than that at the first workout, beginning with stage 3. CONCLUSIONS AND CLINICAL RELEVANCE: Serum COMP concentrations changed significantly in response to exercise. Exercise may enhance movement of COMP into the circulation as well as change the basal turnover rate of COMP.     

The Effects of Verapamil Hydrochloride on Electrocardiographic (ECG) Parameters of Domestic Donkey (Equus asinus)

Verapamil hydrochloride, a calcium channel blocker, has been used in domestic animals. Its effects on electrical activities of the heart of donkeys were studied in this preliminary research work. This experiment was carried out on 10 healthy donkeys ranging in age from 4 to 7 years and mean body weight of 155 ± 18.6 kg. The electrocardiogram (ECG) was recorded on a base apex lead before (for 3 days), during, and after verapamil injection (10, 20, 30, 40, 50, and 60 minutes). Verapamil hydrochloride (0.3 mg/kg body weight) was given via catheterizaion as an intravenous bolus over 2 minutes. Heart rate, rhythm, ECG morphology, amplitude, durations, and intervals were measured and taken into consideration and values were compared. Results showed that heart rate was significantly increased at the time of injection from 55 ± 10.7 before injection to 77.61 ± 12.6 beats per minute after injection (P < .05). Duration of P and T waves; P-R interval, and also P-R segment were increased (P < .05). However, duration of QRS complex, P-P and R-R intervals, and S-T segment were significantly decreased after verapamil injection (P < .05). Sinus arrest (2 cases), bradycardia (1 case), and wandering pacemaker (1 case) were recorded before treatment and verapamil injection did not affect these arrhythmias, except in one case in which sinus arrest disappeared. However, after injection of verapamil, four types of arrhythmias (wandering pacemaker [WPM], sinus tachycardia, 1^st degree AVB, and 2^nd degree AVB) were recognized. These arrhythmias (with the exception of tachycardia) can be related to the increase of vagal tone activity that might be attributed to the negative effect of verapamil on SA and atrioventricular block [AV] nodes.     

Plasma renin activity and aldosterone and vasopressin concentrations during incremental treadmill exercise in horses.

Six untrained mares were subjected to incremental treadmill exercise to examine exercise-induced changes in plasma renin activity (PRA) and plasma aldosterone (ALDO) and plasma arginine vasopressin (AVP) concentrations. Plasma renin activity, ALDO and AVP concentrations, and heart rate (HR) were measured at each step of an incremental maximal exercise test. Mares ran up a 6 degree slope on a treadmill set at an initial speed of 4 m/s. Speed was increased 1 m/s each minute until HR reached a plateau. Plasma obtained was stored at -80 C and later was thawed, extracted, and assayed for PRA and ALDO and AVP values by use of radioimmunoassay. Exercise caused significant increase in HR from 40 +/- 2 beats/min (mean +/- SEM) at rest to 206 +/- 4 beats/min (HRmax) at speed of 9 m/s. Plasma renin activity increased from 1.9 +/- 1.0 ng/ml/h at rest to a peak of 5.2 +/- 1.0 ng/ml/h at 9 m/s, paralleling changes in HR. Up to treadmill speed of 9 m/s, strong linear correlations were obtained between exercise intensity (and duration) and HR (r = 0.87, P less than 0.05) and PRA (r = 0.93, P less than 0.05). Heart rate and PRA reached a plateau and did not increase when speed was increased from 9 to 10 m/s. Plasma ALDO concentration increased from 48 +/- 16 pg/ml at rest to 191 +/- 72 pg/ml at speed of 10 m/s. Linear relation was found between exercise intensity (and duration) and ALDO concentration (r = 0.97, P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)     

Haemosiderin deposition in Donkey (Equus asinus) livers: Comparison of quantitative histochemistry for iron and liver iron content

Post mortem liver samples from 12 donkeys (Equus asinus) aged 21-57 years (4 females, 1 stallion, 7 geldings), were assessed chemically for copper and iron content on a wet weight basis and histologically for stainable iron. Chemical liver copper content ranged from 2.7 to 4.8 μg/g (mean 3.5 ± 0.05 μg/g). Chemical liver iron content ranged from 524 to 5010 μg/g (mean 1723 ± 1258 μg/g). Histochemical iron was measured morphometrically using a computer-based image analysis system; percentage section area staining for iron ranged from 0.84% to 26.69% (mean 10.82 ± 8.36%). There was no clear correlation, within the wide range of iron values, between histochemically demonstrable iron and chemically measured iron content. No clear age-related increase was apparent for either parameter in these aged donkeys. The accumulation of iron in the liver of donkeys may represent a physiological haemosiderosis rather than pathological haemochromatosis.     

Pharmacokinetics and cardiopulmonary effects of guaifenesin in donkeys

Five donkeys and three horses were given guaifenesin, intravenously, by gravity administration, until recumbency was produced. The time and dose required to produce recumbency, recovery time to sternal and standing were recorded. Blood samples were collected for guaifenesin assay at 10, 20, 30, 40, 50, 60 min, and 2, 3, 4 and 6 h after guaifenesin administration. Serum was analysed for guaifenesin using HPLC and pharmacokinetic values were calculated using a computer software package (RSTRIP). In donkeys, heart and respiratory rates and blood pressures were recorded before and at 5-min intervals during recumbency. Arterial blood samples were collected before and at 5 and 15 min intervals during recumbency for analysis of pH, CO₂, and O₂. anova was used to evaluate dynamic data, while t -tests were used for kinetic values.
Respiratory rate was decreased significantly during recumbency, but no other significant changes from baseline occurred. The mean (±SD) recumbency dose of guaifenesin was 131 mg/kg (27) for donkeys and 211 mg/kg (8) for horses. Recovery time to sternal (min) was 15 (SD, 11) for donkeys and 34 (SD, 1.4) for horses. Time to standing was 32 min for donkeys and 36 min for horses. Calculation of AUC (area under the concentration–time curve) (μg.h/mL) (dose-dependent variable) was 231 (SD, 33) for donkeys and 688 (SD, 110) for horses. The clearance ( CL ) (mL/h.kg) was 546 (SD, 73) for donkeys, which was significantly different from 313 (SD, 62) for horses. Mean residence time ( MRT ) (h) was 1.2 (SD, 0.1) for donkeys and 2.6 (SD, 0.5) for horses. Volume of distribution V _d(area) (mL/kg) was 678 (SD, 92) for donkeys and 794 (SD, 25) for horses. At the rate of administration used in this study, donkeys required less guaifenesin than horses to produce recumbency, but cleared it more rapidly.     

Isoproterenol-induced maximal heart rate in normothermic and hyperthermic horses

The heart rate (HR) induced by maximal beta-adrenergic activation, which was elicited by infusion of isoproterenol, was studied in 8 healthy horses before (control) and after hyperthermia was induced by IV administration of 2,4-dinitrophenol (DNP). Isoproterenol was administered IV at 1.0 micrograms.kg-1.min-1 for 3 minutes, and the HR was determined during the final 30 seconds of the infusion. As the rectal temperature increased (P less than 0.001) from 38.2 +/- 0.1 C (mean +/- SEM; normothermic control) to 40.1 +/- 0.1 C at 60 minutes after DNP administration, the isoproterenol-induced HR also increased from 198 +/- 4 beats/min (control) to 214 +/- 4 beats/min (P less than 0.001). It appeared that the values of HR achieved with maximal beta-adrenergic activation were augmented by the hypermetabolic, hyperthermic state induced by DNP.     

Circulatory and muscle metabolic responses to draught work compared to increasing trotting velocities

Circulatory and muscle metabolic responses were studied in 10 horses which all performed incremental draught work at a low trotting speed on a treadmill (D-test) and also exercise with gradually increasing velocities (S-test). Exercise was continued until the horses could no longer maintain the weights above the floor or maintain speed trotting without changing gait to a gallop. Muscle biopsies were taken from the gluteus and the semitendinosus muscles before, and immediately after, exercise. The heart rate (HR) increased linearly with both increasing draught resistance and velocity and reached mean values of 212 and 203 beats/min, respectively. Blood lactate levels increased exponentially to mean values of 12.9 and 7.9 mmol/litre in the two tests. Both HR and blood lactate levels were significantly higher at the cessation of work in the D-test compared to the S-test. The relationship between HR and blood lactate response in the S-test was similar to that in the D-test. The red cell volume was determined after a standardised exercise tolerance test and was significantly correlated both to the weightloading and to the velocity, producing a HR of 200 beats/min. The changes seen in muscle glycogen and glucose-6-phosphate were similar in the two tests, whereas significantly higher lactate levels and lower creatine phosphate and adenosine triphosphate levels were seen in the D-test compared to the S-test. It was concluded that high oxidative capacity is of importance both for fast trotting and for draught work.(ABSTRACT TRUNCATED AT 250 WORDS)     

Physiological and blood biochemical variables in horses exercising on a treadmill submerged in water

The blood lactate concentration (LA) and heart rate (HR) of 10 horses exercising in water on a treadmill were examined. With the water at 10 and 50% of the withers height (WH), the blood LA increased up to mean values around 1.9 mm during the standardized exercise test (SET) until after step 3 of 5 (each step lasted 5 min, speed increasing step by step). Thereafter, blood LA of horses remained constant, while with the water at 80% of WH, the blood LA decreased from the mean peak of 2.16 ± 0.62 mm after the 4th step. The HR of the horses increased to 132 ± 14 beats/min until the 3rd step of SET with the water at 10% of WH, up to the 2nd step with the water at 50% (134 ± 10 beats/min) and up to the 1st step only with the water at 80% of WH (134 ± 10 beats/min). In another SET, horses were exercised five times for 5 min at the maximal attainable speed of 5.5 m/s in water at 20% of the withers height in step 1, 35% in step 2, 49% in step 3, 63% in step 4 and 77% in step 5. On using this SET, blood LA increased to 1.91 ± 0.25 mm until after the 2nd step and decreased after the 3rd step. The HR increased between before commencing SET and the 1st step (143 ± 13 beats/min) and remained constant thereafter. In conclusion, increasing water height and speed of exercise does not augment continuously blood LA and HR of horses exercising in water treadmills.     

Heart rate and salivary cortisol concentrations in foals at birth

Heart rate (HR), HR variability (HRV) and salivary cortisol concentrations were determined in foals (n = 13) during the perinatal phase and until 5 months of age. In the fetus, HR decreased from 77 ± 3 beats/min at 120 min before birth to 60 ± 1 beats/min at 5 min before birth (P <0.01). Within 30 min of birth, HR increased to 160 ± 9 beats/min (P <0.01). Salivary cortisol concentrations immediately after birth were 11.9 ± 3.6 ng/mL and within 2 h increased to a maximum of 52.5 ± 12.3 ng/mL (P <0.01). In conclusion, increases in HR and salivary cortisol concentrations in foals are not induced during parturition, but occur immediately after birth.     

Does Acupuncture Acutely Affect Heart Rate Variability in Horses?

One of the mechanisms by which acupuncture (AP) exerts its purported effects involves modulation of the autonomic nervous system. Heart rate variability (HRV) noninvasively and quantitatively assesses autonomic nervous system activity. We hypothesized that AP treatment would acutely affect HRV by affecting autonomic tone. Eleven horses received three treatments in random order on different days: AP, placement of AP needles at eight AP points; sham AP (SAP), placement of eight AP needles at non-AP points; and control, no needles inserted. A Holter monitor recorded an electrocardiogram for 40 minutes during each treatment session and was analyzed over three periods: 10 minutes of initial “baseline” before AP and/or SAP, the first 10 minutes of a 20-minute AP/SAP/control “treatment”, and the first 10 minutes “post”-AP/SAP/control. RR intervals were measured during each period after the electrocardiograms were inspected and filtered, and mean heart rate (HR), low-frequency (LF) power (0.01–0.07 Hz), high-frequency (HF) power (0.07–0.6 Hz), and LF-to-HF ratio were calculated for each period. Baseline HR decreased with sequential experiments. Within experiments, HF decreased and LF-to-HF ratio increased reciprocally with time. These results suggest that parasympathetic tone decreased over the course of the experiment, perhaps, because of the stress of being restrained. Consequently, HRV indices were either not acutely affected by AP over the intervals studied or autonomic responses to being restrained may have masked any autonomic response to AP.     

Electrocardiographic parameters in the clinically healthy Zamorano-leones donkey

Limited information exists regarding electrocardiographic parameters in clinically healthy donkeys. The study was carried out in 75 healthy adult animals (40 females and 35 males) using the Einthoven standard II and base-apex leads. The P wave showed usually a bifid shape deflection. The QRS complex of the donkeys appeared in several forms: QR and R were the most frequent in limb lead II, and QS and QR in the base-apex lead. Most T waves presented a simple negative configuration in lead II and biphasic shape in the base-apex one. Mean heart rate value was 52 beats per minute. The direction of the QRS vector in lead II had a mean value of 91.4°. We observed a lack of detected arrhythmias. Statistically significant differences were observed between sexes for several parameters. The electrocardiogram of Zamorano-leones donkey differs in several duration, amplitude and morphologic parameters from that of several breeds of horses and donkeys. This fact justifies obtaining values for a specific breed against which to compare values for the same breed.     

Pharmacokinetics of Tramadol and Its Metabolites M1, M2, and M5 in Donkeys after Intravenous and Oral Immediate Release Single-Dose Administration

Tramadol (T) is a centrally acting analgesic structurally related to codeine and morphine. Recently, T has been reported to be metabolized faster to inactive metabolites in goats, dogs, and horses than in cats. Clinical effectiveness of T has been questioned in species that mainly metabolize this molecule to inactive metabolites, suggesting that this drug could be not suitable as effective and safe treatment for pain as in humans. The purpose of the study is to determine the pharmacokinetics of T and its main metabolites in donkeys to evaluate its prospective use in clinical practice. The subjects were 12 male donkeys, 6 to 9 years old and weighing 300 to 380 kg. Each subject received a single dose of 2.5 mg/kg T either orally or intravenously. Plasma T, O-desmethyltramadol (M1), N-desmethyltramadol (M2), and N-,O-didesmethyltramadol (M5) concentrations were evaluated by high-pressure liquid chromatography (HPLC). Pharmacokinetic parameters in both administrations were calculated according to a non-compartmental model. After intravenous administration, T was detectable up to 10 hours, whereas M1, M2, and M5 were detectable from 15 minutes up to 6 hours. The total amount of M2 was greater than M1, which was greater than M5. The T area under the concentration/time curve (AUC), T_1/2 λz (terminal half-life), and Cl/F (Clearance/F where F is the fraction of the drug absorbed) were 14,522 ± 2,554 h/ng/mL, 1.55 ± 0.74 hours, and 167 ± 22.3 mL/h/kg, respectively. After oral administration, T was detectable up to 8 hours to a lower extent than after the intravenous route. The total amount of M2 was greater than M5, which was greater than M1. The T AUC, T_1/2 λz, and Cl/F were 4,624 ± 2,002 h/ng/mL, 4.22 ± 2.32 hours, and 495 ± 170 mL/h/kg, respectively. The bioavailability of the oral formulation was 11.7 ± 5.1%. In conclusion, despite the effectiveness of intravenous administration of T, oral administration did not reach the minimum plasma concentration of both M1 and parental drug reported in humans as needed to achieve analgesia in donkeys.     

Influence of gastrointestinal tract disease on pharmacokinetics of lidocaine after intravenous infusion in anesthetized horses

OBJECTIVE: To determine the disposition of lidocaine after IV infusion in anesthetized horses undergoing exploratory laparotomy because of gastrointestinal tract disease. ANIMALS: 11 horses (mean +/- SD, 10.3 +/- 7.4 years; 526 +/- 40 kg). PROCEDURE: Lidocaine hydrochloride (loading infusion, 1.3 mg/kg during a 15-minute period [87.5 microg/kg/min]; maintenance infusion, 50 microg/kg/min for 60 to 90 minutes) was administered IV to dorsally recumbent anesthetized horses. Blood samples were collected before and at fixed time points during and after lidocaine infusion for analysis of serum drug concentrations by use of liquid chromatography-mass spectrometry. Serum lidocaine concentrations were evaluated by use of standard noncompartmental analysis. Selected cardiopulmonary variables, including heart rate (HR), mean arterial pressure (MAP), arterial pH, PaCO2, and PaO2, were recorded. Recovery quality was assessed and recorded. RESULTS: Serum lidocaine concentrations paralleled administration, increasing rapidly with the initiation of the loading infusion and decreasing rapidly following discontinuation of the maintenance infusion. Mean +/- SD volume of distribution at steady state, total body clearance, and terminal half-life were 0.70 +/- 0.39 L/kg, 25 +/- 3 mL/kg/min, and 65 +/- 33 minutes, respectively. Cardiopulmonary variables were within reference ranges for horses anesthetized with inhalation anesthetics. Mean HR ranged from 36 +/- 1 beats/min to 43 +/- 9 beats/min, and mean MAP ranged from 74 +/- 18 mm Hg to 89 +/- 10 mm Hg. Recovery quality ranged from poor to excellent. CONCLUSIONS AND CLINICAL RELEVANCE: Availability of pharmacokinetic data for horses with gastrointestinal tract disease will facilitate appropriate clinical dosing of lidocaine.